M3 Launches MDLinxCME App, Offering Physicians Unique, Interactive CME Activities Across Numerous Specialty Topics

May 20, 2014

5th App from MDLinx, a leading healthcare brand where physicians find the most up-to-date, valuable clinical and medical information, helping them make the most informed decisions for the health of their patients.

Washington, DC (PRWEB) May 15, 2014

The new innovative MDLinxCME App was created to help practitioners fulfill their continuing medical education (CME/CE) requirements and enhance their CME experience — right on their Apple and Android devices. All CME activities are accredited by ACCME, ACPE, ANCC-COA, CaBRN and CDR.

“Millions of physicians, worldwide, count on MDLinx daily, over 600,000 in the US alone,” comments Lisa Damico, Director of Marketing, MDLinx, a part of M3 Group. “We deliver the latest, most up-to-date clinical and medical information to our members, through the latest and most up-to-date platforms available. That’s why we partnered with RealCME to develop the MDLinxCME App, a new, comprehensive and convenient way for today’s busy physicians to fulfill their continuing medical educational requirements.”

“MDLinx has been enthusiastically participating in online CME programs supported on the RealCME platform for over two years,” remarks Steven Haimowitz, MD, President of RealCME. “We’re excited about now providing their physician membership with the opportunity to participate via their mobile devices, which is increasingly becoming a preferred channel for CME.”

Additional MDLinxCME App features include:

Convenient, free, online/mobile access to CME activities. Progress is synced across both MDLinx web and mobile platforms, allowing the user to switch seamlessly between computer and mobile device while working on each activity. For example, start an activity on your laptop and finish it on the smart phone.

Robust personal CME toolset to help track certificates, credits and scores. All completed credits are tracked automatically in your personal CME toolset. Copies of certificates are emailed directly to the physician user.

Wide variety of engaging activity formats, with instant built-in feedback from esteemed experts and CME providers. Users participate in activities that integrate authentic decision-making opportunities, peer-to-peer interactions, and expert discussions.

Personalized CME Portfolio Report every three months. Users receive a personalized summary of the CME activities both started and completed, progress against your goals, and a summary of mastery by topic.

The new MDLinxCME App can be conveniently downloaded from the App Store and from Google Play. Additional MDLinx apps include: SmartestPCP, SmartestONC, MDLinx Oncology, and MDLinx Survey.

About M3 Group

The M3 Group operates in the US, Asia, and Europe with over 2.5 million physician members globally via its physician websites such as http://www.m3.com, http://www.mdlinx.com,http://research.m3.com, http://www.doctors.net.uk, medigate.netand medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry.These services include medical education, ethical drug promotion, market research, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.